Market closedNon-fractional

Dyne Therapeutics/DYN

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Dyne Therapeutics

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Ticker

DYN

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Waltham, United States

Employees

143

DYN Metrics

BasicAdvanced
$3.4B
Market cap
-
P/E ratio
-$3.91
EPS
1.00
Beta
-
Dividend rate
$3.4B
1
21.828
20.281
4.573
5.568
-40.98%
-71.50%
6.32
6.32
-10.35
17.57%
10.06%

What the Analysts think about DYN

Analyst Ratings

Majority rating from 10 analysts.
Buy

DYN Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$66M
-1.50%
Profit margin
0.00%
NaN%

DYN Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 1.25%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.08
-$0.99
-$1.09
-$0.81
-
Expected
-$0.81
-$0.83
-$0.92
-$0.80
-$0.72
Surprise
33.75%
18.92%
18.91%
1.25%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Dyne Therapeutics stock?

Dyne Therapeutics (DYN) has a market cap of $3.4B as of July 04, 2024.

What is the P/E ratio for Dyne Therapeutics stock?

The price to earnings (P/E) ratio for Dyne Therapeutics (DYN) stock is 0 as of July 04, 2024.

Does Dyne Therapeutics stock pay dividends?

No, Dyne Therapeutics (DYN) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Dyne Therapeutics dividend payment date?

Dyne Therapeutics (DYN) stock does not pay dividends to its shareholders.

What is the beta indicator for Dyne Therapeutics?

Dyne Therapeutics (DYN) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Dyne Therapeutics stock

Buy or sell Dyne Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing